The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Zentalis Pharmaceuticals Inc shares valued at $29,435 were sold by Epperly Melissa B, on Feb 12 ’24. At $11.44 per share, Epperly Melissa B, sold 2,573 shares. The insider’s holdings dropped to 451,449 shares worth approximately $5.74 million following the completion of this transaction.
Also, Gallagher Cam sold 1,173 shares, netting a total of over 13,419 in proceeds. Following the sale of shares at $11.44 each, the insider now holds 643,277 shares.
Before that, Gallagher Cam had sold 11,552 shares from its account. In a trade valued at $133,310, the President traded Zentalis Pharmaceuticals Inc shares for $11.54 each. Upon closing the transaction, the insider’s holdings decreased to 11,552 shares, worth approximately $8.19 million.
As published in a research note from Wedbush on November 08, 2023, Zentalis Pharmaceuticals Inc [ZNTL] has been rated down from an Outperform to a Neutral and the price target has been revised to $12 from $38. Analysts at Leerink Partners downgraded the stock from ‘”an Outperform”‘ to ‘”a Market perform”‘ outlook in a report released in early November. As of July 12, 2022, Cowen has initiated its “an Outperform” rating for ZNTL. Earlier on April 06, 2022, Wells Fargo initiated its rating. Their recommendation was “an Overweight” for ZNTL stock.
Analyzing ZNTL Stock Performance
During the last five days, there has been a drop of approximately -13.71%. Over the course of the year, Zentalis Pharmaceuticals Inc shares have dropped approximately -16.11%. Shares of the company reached a 52-week high of $18.07 on 02/28/24 and a 52-week low of $10.57 on 02/13/24. A 50-day SMA is recorded $13.92, while a 200-day SMA reached $17.72. Nevertheless, trading volume fell to 0.81 million shares from 0.98 million shares the previous day.
Support And Resistance Levels for Zentalis Pharmaceuticals Inc (ZNTL)
According to the 24-hour chart, there is a support level at 12.42, which, if violated, would cause prices to drop to 12.14. In the upper region, resistance lies at 13.15. The next price resistance is at 13.60. RSI (Relative Strength Index) is 39.81 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.55, which suggests the price will decrease in the coming days. Percent R is at 96.47%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
